A Study of Safety and Drug Levels of HIB210 in Healthy Volunteers
Status:
Recruiting
Trial end date:
2024-04-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to test safety of the investigational product in healthy
volunteers. The main questions it aims to answer is when HIB210 is administered as multiple
doses, is it:
1. Safe
2. Well tolerated
3. Does the body absorb and eliminate HIB210 as expected